Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
The hematopoietic transcription factor Spi-1/PU.1 is an oncoprotein participating to the malignant transformation of proerythroblasts in the Friend erythroleukemia or in the erythroleukemic process developed in spi-1 transgenic mice. Overexpression of Spi-1 in proerythroblasts blocks their differentiation. We have shown that Spi-1 promotes the use of the proximal 5'-splice site during the E1A pre-mRNA splicing and interferes with the effect of TLS (Translocated in LipoSarcoma) in this splicing assay. TLS was identified from chromosomal translocations in human liposarcoma and acute myeloid leukemia. Here, we determine the function of Spi-1 domains in splicing and in the interference with TLS. In transient transfection assays in erythroid cells, we show that the DNA binding domain cooperates with the transactivation domain or the PEST region of Spi-1 to modify the function of TLS in splicing. Interestingly, the 27 C-terminal amino acids, which determine the DNA binding activity of Spi-1, are necessary for the splicing function of Spi-1 as well as for its ability to interfere with TLS. Finally, we demonstrate that in leukemic proerythroblasts overexpressing Spi-1, TLS has lost its splicing effect. Thus, we hypothesize that oncogenic pathways in proerythroblasts may involve the ability of Spi-1 to alter splicing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FUS/TLS, a well-described interacting factor involved in SPI1 splicing activity (50,51), and the SWI/SNF complex, which is also known to interact with SPI1 (52), were recovered, validating the SPI1-RIME approach.”
From HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia (2022) · cites this paper as [50]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 49 · Cited by 26
Research works printed but not linked: 1
- Yang L, Embree LJ and Hickstein DD . (2000). Mol. Cell. Biol., 20, 3345–3354. · doi:10.1128/mcb.20.10.3345-3354.2000 · Paper page
Metadata
- Authors
- Delva, L., Gallais, I., Guillouf, C., Denis, N., Orvain, C., & Moreau-Gachelin, F.
- Affiliations
- Inserm (FR)
- Venue
- Oncogene
- Published
- 2004-04-05
- Volume
- 23
- Issue
- 25
- Pages
- 4389-4399
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2058890884
- Cited by
- 26
- References
- 49
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2012: 1
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ligue Contre le Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- TLS, alternative splicing, erythroleukemia, proerythroblasts, DNA-binding domain, transactivation domain, leukemic transformation
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, Binding Sites, Cell Transformation, Neoplastic, DNA, Leukemia, Erythroblastic, Acute, Protein Binding, Proto-Oncogene Proteins, RNA Precursors, RNA Splicing, RNA, Neoplasm, Structure-Activity Relationship, Transfection, Neoplastic Stem Cells, Transcriptional Activation, Trans-Activators, Erythroid Precursor Cells, Protein Structure, Tertiary, Adenovirus E1A Proteins, Genes, Reporter, RNA Splice Sites, RNA-Binding Protein FUS, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells. https://app.cochat.ai/papers/10.1038/sj.onc.1207578
- The paper
- Delva, L., Gallais, I., Guillouf, C., Denis, N., Orvain, C., & Moreau-Gachelin, F. (2004). Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells. Oncogene. https://doi.org/10.1038/sj.onc.1207578
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.